Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units

Bone Marrow Transplantation

Volumn 43, Issue 12, 2009, Pages 935-940

  Brunstein, C G ^a   Barker, J N ^a   Weisdorf, D J ^a   DeFor, T E ^a   McKenna, D ^a   Chong, S Y ^a   Miller, J S ^a   McGlave, P B ^a   Wagner, J E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ADMINISTRATION OF DRUGS, FOOD AND CHEMICALS; ADULT; ARTICLE; BONE MARROW INJECTION; CANCER RELAPSE; CAUSE OF DEATH; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DEATH; ENGRAFTMENT; FEASIBILITY STUDY; GRAFT FAILURE; HEMATOLOGIC MALIGNANCY; HLA SYSTEM; HUMAN; INTRAVENOUS ADMINISTRATION; MYELOABLATIVE CONDITIONING; NEUTROPHIL; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ADULT; BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HISTOCOMPATIBILITY TESTING; HUMANS; NEUTROPHILS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649870299     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.417     Document Type: Article

References (24)

1. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, McGlave PB, Miller JS et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343-1347.
2. Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 2004; 351: 2265-2275.
3. Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A et al Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 2004; 351 2276-2285.
4. Wagner JE. A new route to the stem-cell niche. Lancet Oncol 2008; 9: 812-814.
5. Zhong JF, Zhan Y, Anderson WF, Zhao Y. Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation. Blood 2002; 100: 3521-3526.
6. Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y et al. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood 2003; 101: 2924-2931.
7. Kushida T, Inaba M, Hisha H, Ichioka N, Esumi T, Ogawa R et al. Intra-bone marrow injection of allogeneic bone marrow cells: A powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 2001; 97: 3292-3299.
8. Mazurier F, Doedens M, Gan OI, Dick JE. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 2003; 9: 959-963.
9. Yahata T, Ando K, Sato T, Miyatake H, Nakamura Y, Muguruma Y et al A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 2003; 101: 2905-2913.
10. Cui J, Wahl RL, Shen T, Fisher SJ, Recker E, Ginsburg D et al. Bone marrow cell trafficking following intravenous administration. Br J Haematol 1999; 107: 895-902.
11. Hagglund H, Ringden O, Agren B, Wennberg L, Remberger M, Rundquist L et al. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transplant 1998; 21: 331-335.
12. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325-4336.
13. Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR et al. Processing and cryopreservation of placental/ umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995; 92: 10119-10122.
14. Brunstein CG, Barker JN, Weisdorf DJ, DeFor TE, Miller JS, Blazar BR et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: Impact on transplantation outcomes in 110 adults with hematologic disease. Blood 2007; 110: 3064-3070.
15. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
16. Lin DY. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997; 16: 901-910.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
18. Frassoni F, Gualandi F, Podesta M, Raiola AM, Ibatici A, Piaggio G et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: A phase I/II study. Lancet Oncol 2008; 9: 831-839.
19. Ibatici A, Raiola AM, Podestà M, Gualandi F, Sessarego N, Parodi A et al. Direct intra-bone marrow injection of unrelated umbilical cord blood cells overcomes the problem of delayed engarftment and improves the feasibility of hematopoietic transplant in adult patients. Blood 2007; 110: 105a.
20. Khoury HJ, Loberiza Jr FR, Ringden O, Barrett AJ, Bolwell BJ, Cahn JY et al. Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation. Blood 2006; 107: 1712-1716.
21. Brunstein CG, Defor T, Wagner JE. Umbilical cord blood transplantation (UCBT) at the university of Minnesota: Impact of double unit and fludarabine on engraftment after myeloablative conditioning. Blood 2006; 108: 888a.
22. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001; 344: 1815-1822.
23. MacMillan M, Weisdorf DJ, Brunstein CG, Cao Q, Defor T, Verneris MR et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: Analysis of risk factors. Blood 2008; e-pub ahead of print 7 November 2008.
24. Slayton WB, Li XM, Butler J, Guthrie SM, Jorgensen ML, Wingard JR et al. The role of the donor in the repair of the marrow vascular niche following hematopoietic stem cell transplant. Stem Cells 2007; 25: 2945-2955.